A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
about
Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failureAdenosine monophosphate-activated protein kinase in diabetic nephropathyGenetics of Insulin Resistance and the Metabolic SyndromeInfluence of Acute and Chronic Exercise on Glucose UptakeAdiponectin signaling and function in insulin target tissuesPerspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in ObesityInsulin resistance in clinical and experimental alcoholic liver diseaseAdipokines - removing road blocks to obesity and diabetes therapyPolyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal CancerAging and adipose tissue: potential interventions for diabetes and regenerative medicineThe cell biology of fat expansionEndocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.Aging and caloric restriction impact adipose tissue, adiponectin, and circulating lipidsCombined immunotherapy with "anti-insulin resistance" therapy as a novel therapeutic strategy against neurodegenerative diseases.Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets.Adiponectin regulates contextual fear extinction and intrinsic excitability of dentate gyrus granule neurons through AdipoR2 receptors.Differential adiponectin signalling couples ER stress with lipid metabolism to modulate ageing in C. elegansAdiponectin/adiponectin receptor in disease and aging.New insight into adiponectin role in obesity and obesity-related diseases.Adipsin is an adipokine that improves β cell function in diabetes.Disease-Modifying Effect of Adiponectin in Model of α-SynucleinopathiesYounger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study.hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signalingDevelopment of second generation peptides modulating cellular adiponectin receptor responses.Cell Biology. Ronning after the adiponectin receptors.Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response.Weight loss by Ppc-1, a novel small molecule mitochondrial uncoupler derived from slime moldSmall molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseasesDietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.Adipokines as drug targets in diabetes and underlying disturbances.Possible new therapeutic approach for obesity-related diseases: Role of adiponectin receptor agonists.Adiponectin-mediated antilipotoxic effects in regenerating pancreatic isletsBiomarkers of insulin sensitivity and insulin resistance: Past, present and future.Tumor expression of adiponectin receptor 2 and lethal prostate cancerObesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance.Rapid Alterations in Perirenal Adipose Tissue Transcriptomic Networks with Cessation of Voluntary Running.Association between the level of circulating adiponectin and prediabetes: A meta-analysis
P2860
Q26745026-D2C3FAD2-550E-41E9-9396-F4BCAFA2581CQ26745623-96B51206-D1BC-4C08-B9D4-2DD58F63051EQ26745624-26733432-FED7-405E-9DD0-6A6DD7879DD4Q26748964-B1FED295-17B5-4849-BF58-0DF5CEB9B804Q26753354-AA58A3C7-152F-4F6C-92A5-0281C36D9702Q26777180-CE1A3CCD-B7D4-458F-9BD3-1576184D9383Q26865988-CF30EB33-031D-4A58-923C-1665C2AE982FQ26995825-2FB25D2F-1339-4D9C-B4ED-A7E6A6901AC0Q28071957-98E27F4C-E27F-47D1-B27B-7D81BAA167D6Q28079178-0604E259-0D88-4CCF-998E-40F556F495E1Q28084054-56A94FEE-7375-4CB3-BA58-1E4DA9352E34Q33597839-A5A673E8-D217-4734-A74F-3E60755C2C9FQ33638932-983C355C-DEFF-4C3F-80FA-90A7445EC2F9Q33731321-0DBFA103-B91B-48D6-AF58-D748A9720467Q33755566-C142E22C-229B-4A99-9B0E-2B747E0EDA4CQ33808884-C132A828-978D-4EF8-8C22-AF08E00317F5Q33854987-A7177DF5-A83B-4247-A3E3-7D8BAA7A8DDFQ33894892-E2798D8E-4FA1-483A-B496-3B50CB9480B8Q33914270-ED824904-6261-4FB3-BB2F-C4848C8C4D0BQ33943727-662E9B61-F3F4-4498-A0E9-E14A54E20547Q34025740-C2B48A0D-8229-4909-AEC0-8858D507C7D6Q34026035-1E506882-1F7B-40E0-9FD7-C905279470F7Q34109255-F1ABBCF1-0A32-4D3C-BFFA-B11AA0C72E31Q34217628-E9C04B23-913D-4DB4-8ED4-F12A6521D4AEQ34360125-B2720E13-7A8C-43BC-A92B-96640C09DFECQ34393247-951D6AEA-6877-4712-85D4-57EA461E9D97Q34485836-F7E51903-2F3F-4424-96D5-BA7301DB9457Q34501403-7C78FFFF-AD32-4443-9D83-4760F4FC02B7Q35039346-4438EDBC-C545-478A-A68B-BC00E074ADF0Q35069125-8D856CE3-0481-44A7-AB03-55DA8D7135C6Q35224775-82416E84-A8E5-4D18-A1B9-6DE64E5A1F6CQ35239541-F170A5AD-F2AE-41CC-A188-4D38C500A33BQ35415815-953649F5-21E6-4DB0-BB46-D77A197AAEA1Q35571795-F9BA0A7C-9E25-4E53-BD55-A39AE10D9BC8Q35603376-4AA78D4C-0EA8-4851-9FD3-4A763D9324EBQ35652813-FD6E1D9C-572C-4346-879F-6581FFD43E2CQ35784565-F02C08F3-888F-467D-B180-6FAA3A1D1090Q35863452-C106B765-C9A1-4BCA-B3C8-BCE503B6A72DQ35871716-D58D8F7C-11FF-49B5-B0C6-A795ABFBD90AQ35879311-DD596579-4E45-4C14-A7FA-854EC80D959A
P2860
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@ast
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@en
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@nl
type
label
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@ast
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@en
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@nl
prefLabel
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@ast
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@en
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@nl
P2093
P356
P1433
P1476
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
@en
P2093
Akiko Tanaka
Hiroaki Tanabe
Hitomi Ogata
Ken-ichi Hamagami
Koichi Matsuda
Kumpei Tokuyama
Mamiko Yamaguchi
Masato Iwabu
Mikako Shirouzu
Miki Okada-Iwabu
P2888
P304
P356
10.1038/NATURE12656
P407
P577
2013-10-30T00:00:00Z